November 15-20, 2019

November 15-20, 2019

Birmingham, Alabama

Birmingham, Alabama

days
5
4
hours
1
2
minutes
1
8
seconds
3
4
REGISTER
NOW

Scientific Program Abstracts
(Abstracts are on locked PDF documents. Passwords will be distributed by the ABSA office.)

Monday Scientific Program

November 18, 2019

Continental Breakfast in Foyer

7:00 am  -  8:00 am
Foyer

Monday Morning

8:00 am  -  8:25 am

7:00 – 5:00 pm Registration
9:00 – 4:00 pm Vendor Exhibits

8:00 – 8:15 am

Welcome and ABSA International President’s Address

Master of Ceremonies: Dee Zimmerman, Galveston, TX

8:15 – 8:20 am

Local Arrangements Committee Welcome

Debra Sharpe, MPH, RBP(ABSA), Sharpe Solutions International, LLC, Birmingham, AL

8:20 – 8:25 am

Scientific Program Committee Welcome

Jessica McCormick-Ell, PhD, RBP(ABSA), CBSP(ABSA), SM(NRCM), Rutgers University, Newark, NJ

Session I: Arnold G. Wedum Memorial Lecture Award

8:25 am  -  9:30 am

Introduction: Claudia Gentry-Weeks, PhD, Colorado State University, Fort Collins, CO

8:25 – 9:30 am

Biosafety in Clinical Laboratories

Michael Pentella, PhD, D(ABMM), University of Iowa College of Public Health, Iowa City, IA

Exhibits, Posters, and Coffee Break

9:30 am  -  10:00 am

Session II: A Focus on Human Gene Therapy

10:00 am  -  11:00 am

Moderator: Justin Roth, University of Alabama-Birmingham, Birmingham, AL

10:00 – 10:20 am

The US Regulatory Environment is Evolving to Accommodate a Coming Boom in Gene Therapy Research

Daniel Eisenman, PhD, RBP(ABSA), CBSP(ABSA), SM(NRCM), Advarra, Research Triangle Park, NC

10:20 – 10:40 am

Viral-mediated Gene Therapy and Genetically Modified Therapeutics: Occupational Safe Drug Handling in a Health System Pharmacy

Jill E. Blind, PharmD, Nationwide Children’s Hospital, Columbus, OH

10:40 – 11:00 am

Biosafety Challenges with the Use of Viral-mediated Gene Therapy in a Healthcare Setting

Alex M. Brown, BS, The Research Institute at Nationwide Children’s Hospital, Columbus, OH

Session III: Behavior Enhancing Compliance

11:00 am  -  12:00 pm

Moderator: Betsy Matos, PhD, RBP(ABSA), CBSP(ABSA), Iowa State University, Ames, IA

11:00 – 11:20 am

Biosafety Critical Task Analysis as a Means to Mitigate Human Failure in a High-Containment Facility

Anna E. Lawton, BSc, The Pirbright Institute, Pirbright, Woking, United Kingdom

11:20 – 11:40 am

Managing Goal Conflicts in a Biomedical Research Laboratory

Viji Vijayan, RBP(ABSA), Duke-NUS Graduate Medical School, Singapore, Singapore

11:40 – 12:00 pm

Transitioning from Lagging to Leading Indicators: How a Near Miss Program is Changing Safety Culture

Monica Lurtz, PhD, WuXi AppTec, Philadelphia, PA

Exhibits, Posters, and Lunch

12:00 pm  -  1:30 pm

Session IV: Poster Session

12:00 pm  -  1:30 pm

Presenters must be available during the session.

Session V: Invited Speaker

1:30 pm  -  2:30 pm

Introduction: Anthony Troiano, PhD, RBP(ABSA), Environmental Health & Engineering, Inc., Newton, MA

1:30 – 2:30 pm

Making Your Biosafety Message Stick!

Robert Emery, DrPH, CBSP(ABSA), University of Texas Health Science Center at Houston, Houston, TX

 

Session VI: Emerging Issues in Biosafety

3:00 pm  -  4:00 pm

Moderator: Michele Howard, Centers for Disease Control and Prevention, Atlanta, GA

3:00 – 3:20 pm

Risk Assessment and Facility Containment for Research with Gene Drive Arthropods

Sheryl Major, University of California-San Diego, San Diego, CA

3:20 – 3:40 pm

Prion-like Proteins: Implementation of IBC Oversight

Susan Vleck, PhD, RBP(ABSA), Stanford University, Stanford, CA

3:40 – 4:00 pm

Microbial Aerosols in the Modern Microbiology Laboratory

Allan Bennett, MSc, Public Health England, Porton Down, Salisbury, United Kingdom

Section VII: Interesting Topics in Biosafety

4:00 pm  -  5:00 pm

Moderator: Larry Mendoza, RBP(ABSA), Virginia Commonwealth University, Richmond, VA

4:00 – 4:20 pm

Differences in BSO Roles in the Pharmaceutical Industry Versus Academic Laboratories

Rebecca McGirr, MS, RBP(ABSA), Sanofi Pasteur Limited, Toronto, Ontario, Canada

4:20 – 4:40 pm

Liquid Nitrogen Storage in a High-Containment Laboratory-Why AAHL is Moving Away from It

Shane Riddell, CSIRO-Australian Animal Health Laboratory, Geelong, Victoria, Australia

4:40 – 5:00 pm

Utility of the Incident Command System in Laboratory Emergency Management

Kaci VanDalen, MS, National Institutes of Health, Bethesda, MD

Members’ Business Meeting

5:00 pm  -  Close